3 results about "Chronic Cervicitis" patented technology

Devices, systems and methods are provided for treating conditions of the reproductive tract. A number of conditions can afflict the lining and cell layers deeper within the anatomical structures. For example, cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is a condition involving abnormal growth of cells on the surface of the cervix that could potentially lead to cervical cancer in situ (CIS). Other conditions include human papillomavirus (HPV)-related cervical disease, various endometrial diseases, acute and chronic cervicitis, and various infections (e.g. trichomoniasis) to name a few. In some embodiments, treatments eliminate diseased, damaged, abnormal or otherwise undesired cells leaving the tissue framework intact. This allows the tissue to regenerate in a normal fashion, avoiding the formation of scar tissue. When the tissue framework is left intact, the framework structure repopulates with healthy cells, regenerating the normal tissue without altering the structural properties.

The application provides a pharmaceutical composition for treating gynecological inflammation and a preparation method thereof, and belongs to the technical field of medicines. After being subjected to water extraction and alcohol extraction, Sophora flavescens, Phellodendri chinensis, Forsythia suspensa and Ligustrum lucidum are used to obtain traditional Chinese medicine water extracts and traditional Chinese medicine alcohol extracts; the traditional Chinese medicine water extracts are reacted with silver salt and copper salt to obtain traditional Chinese medicine water extract-metal ion complex; the traditional Chinese medicine water extract-metal ion complex is mixed with the traditional Chinese medicine alcohol extracts, sodium taurodeoxycholate, laurocapram and berberine to prepare nanometer drug delivery micelles; and the nanometer drug delivery micelles are added into a hydrogel of chitosan, poloxamer P407 and poloxamer P188 to prepare the pharmaceutical composition for treating gynecological inflammation. The prepared composition has excellent treatment effect and low toxicity, thereby reducing the cost and improving the treatment effect of gynecological diseases such as chronic pelvic inflammatory disease, chronic cervicitis, vaginitis and artificial abortion complications, and has a wide application prospect.

This invention relates to a traditional Chinese medicine composition for treating chronic cervicitis complicated with HPV infection. The composition is made from the following raw materials in parts by weight: 26-34 parts raw Astragalus membranaceus, 26-34 parts Smilax glabra, 11-19 parts Toona sinensis root bark, and 26-34 parts raw Coix lacryma-jobi. This invention also provides the uses of the traditional Chinese medicine composition. In this invention, raw Astragalus membranaceus is the principal ingredient, tonifying Qi and strengthening the body's resistance; Smilax glabra and Toona sinensis root bark clear heat and dry dampness; and raw Coix lacryma-jobi dispels dampness and promotes tissue regeneration, serving as assistant ingredients; the entire formula works synergistically to strengthen the body's resistance, eliminate pathogenic factors, and promote tissue regeneration.